Intermittent fasting in women: what the studies included
Reviewed 16 sourcesPublished by PepVault
Intermittent fasting in women: who the main trials enrolled (share of women, ages, menopause) and what they found for weight, DHEA, estradiol and the cycle.

- Last reviewed
- Sources
- 16
- Questions
- 7
The short answer
The main intermittent fasting weight-loss trials enrolled mostly women: 86% in a year-long alternate-day trial, 82% in a year-long 16:8 trial and 100% in two women-only trials. Women lost as much weight as on a daily calorie cut, and sex hormones held steady over 12 months. The catch: one 5:2 trial lengthened cycles by about two days, and the two trials that split women by menopause excluded the perimenopause.
- In the two year-long trials, 82% and 86% of the volunteers were women.
- Weight loss matched a daily calorie cut over 6 to 12 months.
- Sex hormones held steady over a year; a 4- to 6-hour window lowered DHEA by about 14% in 8 weeks.
- A 5:2 trial lengthened cycles by about two days, and the two hormone trials excluded women in the perimenopause.
Evidence: Randomized trials of 6 to 12 months, most of their volunteers women with overweight or obesity, for weight; hormone and cycle results come from smaller trials, secondary analyses and Ramadan studies, plus one rat study.

Who did the intermittent fasting trials enroll?
Women, mostly. The idea that fasting research was done on men does not hold for the main weight-loss trials: most of their volunteers were women with obesity in their 30s to 50s. What the trials rarely did was split those women by life stage, and the two that did excluded women in the perimenopause, the years of irregular periods before menopause. The table puts the main trials side by side.
| Trial | Pattern and length | Women enrolled | Ages | Menopause status | What it measured in women |
|---|---|---|---|---|---|
| Harvie 2011 | 5:2, about 650 kcal on 2 days a week, against a daily 25% cut; 6 months | 107 of 107 (100%) | 30 to 45 | All premenopausal, regular cycles, no pill for 6 months | Weight, androgens, SHBG, DHEA-S, cycle length1 |
| Hutchison 2019 | 24-hour fasts on 3 days a week, food provided; 8 weeks | 88 of 88 (100%) | Mean 50 | Not given in the abstract | Insulin sensitivity by clamp, weight, fat2 |
| Trepanowski 2017 | Alternate-day fasting against a daily 25% cut; 12 months | 86 of 100 (86%) | 18 to 64, mean 44 | Not split in the paper's summary | Weight, heart risk markers3 |
| Lin 2023 and 2024 | 16:8, eating noon to 8 p.m., against a daily 25% cut; 12 months | 74 of 90 (82%)16 | 18 to 65, mean 44 | Split into pre- and postmenopausal for hormones; perimenopause and irregular cycles excluded16 | Weight; testosterone, DHEA, SHBG; estradiol after menopause only45 |
| Kalam 2023 | 4- to 6-hour eating window; 8 weeks | 23 women analysed | 18 to 65 eligible; postmenopausal group older | 12 premenopausal, 11 postmenopausal; perimenopausal excluded | Weight, androgens, DHEA; estradiol after menopause only6 |
| Lowe 2020 (TREAT) | 16:8; 12 weeks | 46 of 116 (40%) | 18 to 64 | Not split in the paper's summary | Weight, lean mass7 |
| Heilbronn 2005 | 36-hour fasts every other day; 22 days | 8 of 16 (50%) | Not given in the abstract; BMI 20 to 30 | Not split in the paper's summary | Blood sugar after a meal8 |
| Li 2021 | 8-hour eating window; 5 weeks | 18 of 18 (100%) | 18 to 31 | Premenopausal, with PCOS and no ovulation | Weight, testosterone, cycles9 |
| Al Zunaidy 2024 | Ramadan (no food or water in daylight); 4 weeks, no control group | 62 of 62 (100%) | 21 to 42 and 43 to 68 | 31 premenopausal, 31 postmenopausal | Weight, estrogen, progesterone10 |
SHBG (sex hormone binding globulin) is the blood protein that carries testosterone and estradiol. DHEA is a hormone made by the adrenal glands and ovaries that the body turns into estrogens and androgens. BMI is weight against height (pepvault.app/glossary/bmi).

Does intermittent fasting work as well for women?
Yes, and about as well as cutting calories every day. In the women-only 5:2 trial, women lost 6.4 kg on two low days a week against 5.6 kg on a daily cut over six months, a difference too small to count1. In the year-long alternate-day trial, where 86% were women, the fasting group lost 6.0% and the daily-cut group 5.3% of body weight more than the control group3. The year-long 16:8 trial, 82% women, found the same tie: 4.61 kg lost against controls with the eating window, 5.42 kg with the daily cut4.
One women-only trial tipped the other way. When the food was provided and both groups ate 70% of their energy needs, women who fasted for 24 hours on three days a week lost more weight and fat, and lowered LDL cholesterol more, than women eating the same amount spread over every day2. That was over 8 weeks, with every meal supplied, so it shows what the pattern can do when intake is held exactly.
PepVault keeps your weigh-ins on one chart, so you can see whether a fasting plan is moving your weight the way the trials did. Track your weight in PepVault
Does intermittent fasting change women's hormones?
Over a year, not measurably. In the 12-month 16:8 trial, total testosterone, DHEA and SHBG did not change in premenopausal or postmenopausal women, and estradiol, estrone and progesterone did not change in women after menopause5. A 2026 systematic review of six studies came to the same reading for women with obesity: the randomized trials found no significant change in testosterone, estrogen, progesterone, LH, cortisol, DHEA or SHBG12.
The one change on record came from a much tighter window. With only 4 to 6 hours of eating a day for 8 weeks, DHEA fell by 14% in premenopausal and 13% in postmenopausal women, while testosterone, androstenedione and SHBG held still6. The authors note the values stayed inside the normal range. The wider 8-hour window over 12 months showed no DHEA drop5. Our guide at pepvault.app/guides/dhea-for-women covers what DHEA does in women.
In the 5:2 trial, both diets raised SHBG and lowered the free androgen index (how much testosterone is free to act), changes that come with weight loss in either form1.
Does intermittent fasting affect your period?
The best data come from the women-only 5:2 trial, the only randomized trial in the table that recorded cycle length (data for 83% to 87% of the women). Over six months, cycles averaged 29.7 days on the 5:2 diet against 27.4 days on the daily cut, about two days longer, a statistically significant difference1.
In women with polycystic ovary syndrome (PCOS) who were not ovulating, five weeks of an 8-hour eating window went the other way: cycles became more regular in 11 of 15 women who finished, and testosterone fell9. That trial had no control group. Our draft guide pepvault.app/guides/glp-1-and-pcos covers the GLP-1 side of PCOS.
Ramadan is a stricter pattern, with no food or water from dawn to sunset. In a survey of 80 female students, 11.3% had an irregular pattern in the three months before Ramadan, 30% during it and 16.3% in the three months after; those who fasted more than 15 days had more changes11. The warning stories about fasting and fertility trace back largely to one rat study, the authors of the 2023 hormone study write: young female rats went without food a full day every other day for 12 weeks, and their estrous cycle (the rat's version of the menstrual cycle) was disrupted and LH, a hormone that triggers ovulation, fell13. The rats were 3 months old, which those authors equate to a 9-year-old child6.
Commonly reported: hunger and irritability in the first weeks, and, in women's own accounts online, periods that come late or stop on strict plans.
When to get help If you miss three periods in a row, see your doctor; the NHS lists sudden weight loss among the common causes14.
Does intermittent fasting work after menopause?
In the two trials that split women by menopause, it worked the same on both sides of it. Over 8 weeks with a 4- to 6-hour window, premenopausal women lost 3% of body weight and postmenopausal women 4%, with no difference between the groups, and postmenopausal women lost more visceral fat, the fat around the organs6. Over 12 months of 16:8, weight fell in premenopausal and postmenopausal women alike, against controls5.
After menopause, estradiol, estrone and progesterone held steady in both trials56. A Ramadan study of 31 premenopausal and 31 postmenopausal women found weight and body fat fell in both groups over four weeks; estrogen fell before menopause and rose after it, though that study had no comparison group10.
Muscle is the open question after menopause. A Spanish randomized trial of 78 postmenopausal women aged 50 to 65 is testing an 8-hour window with and without resistance training, with muscle measured by MRI; its protocol was published in 202515. Our guide pepvault.app/guides/glp-1s-and-menopause covers the GLP-1 trials in the same age group.
Do women's blood sugar levels respond differently to fasting?
In one small early study, yes. Eight women and eight men without obesity fasted for 36 hours every other day for three weeks. Afterwards the women's blood sugar after a standard meal ran slightly higher than before, while the men's did not change and their insulin response fell8. That study is often quoted as proof fasting is worse for women; it had 8 women, lasted 22 days, and used a fast far longer than 16:8.
In the women-only trial with 24-hour fasts, insulin sensitivity measured by the gold-standard clamp test did not differ between the diets after 8 weeks, though it dipped on the day right after a 24-hour fast2. The year-long alternate-day trial, 86% women, found no difference from a daily cut in fasting glucose or insulin3.
Which women did the studies leave out?
- Women in the perimenopause: excluded by design in the year-long 16:8 trial, along with irregular cycles16, and in the 8-week hormone study6; not split out in the other trials in the table.
- Estradiol before menopause: measured in neither 16:8-type hormone study56; the 8-week study says why: the day of each woman's cycle was not recorded6.
- Women on the pill: excluded from the 5:2 trial for the six months before it1.
- Lean, active young women: the long trials enrolled women with overweight or obesity; outside Ramadan, the one study of women without obesity had eight of them8.
- Pregnant and breastfeeding women: excluded from the hormone study's parent trial and the year-long 16:8 trial, and no trial in the table tested fasting in them616.
The fair summary: for a woman with excess weight before or after menopause, intermittent fasting has year-long randomized evidence behind it, mostly from women, and it matches a daily calorie cut. For the perimenopause, for women at a healthy weight and for fertility, these trials give little to go on. Fasting on a GLP-1 medicine has its own guide: pepvault.app/guides/intermittent-fasting-on-a-glp-1.
PepVault's food log puts each meal on a line across your day at the time you logged it; after five days of meals the line spans your own eating hours, so your real window shows, with the day's protein total under it. Track your food in PepVault
Sources
- Harvie MN, Pegington M, Mattson MP, et al. The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. Int J Obes (Lond). 2011;35(5):714-727. PubMed 20921964
- Hutchison AT, Liu B, Wood RE, et al. Effects of intermittent versus continuous energy intakes on insulin sensitivity and metabolic risk in women with overweight. Obesity (Silver Spring). 2019;27(1):50-58. PubMed 30569640
- Trepanowski JF, Kroeger CM, Barnosky A, et al. Effect of alternate-day fasting on weight loss, weight maintenance, and cardioprotection among metabolically healthy obese adults: a randomized clinical trial. JAMA Intern Med. 2017;177(7):930-938. PubMed 28459931
- Lin S, Cienfuegos S, Ezpeleta M, et al. Time-restricted eating without calorie counting for weight loss in a racially diverse population: a randomized controlled trial. Ann Intern Med. 2023;176(7):885-895. PubMed 37364268
- Lin S, Cienfuegos S, Ezpeleta M, Pavlou V, Runchey MC, Varady KA. Effect of time restricted eating versus daily calorie restriction on sex hormones in males and females with obesity. Eur J Clin Nutr. 2024;78(9):814-817. PubMed 38866976
- Kalam F, Akasheh RT, Cienfuegos S, et al. Effect of time-restricted eating on sex hormone levels in premenopausal and postmenopausal females. Obesity (Silver Spring). 2023;31 Suppl 1:57-62. PubMed 36203273
- Lowe DA, Wu N, Rohdin-Bibby L, et al. Effects of time-restricted eating on weight loss and other metabolic parameters in women and men with overweight and obesity: the TREAT randomized clinical trial. JAMA Intern Med. 2020;180(11):1491-1499. PubMed 32986097
- Heilbronn LK, Civitarese AE, Bogacka I, Smith SR, Hulver M, Ravussin E. Glucose tolerance and skeletal muscle gene expression in response to alternate day fasting. Obes Res. 2005;13(3):574-581. PubMed 15833943
- Li C, Xing C, Zhang J, Zhao H, Shi W, He B. Eight-hour time-restricted feeding improves endocrine and metabolic profiles in women with anovulatory polycystic ovary syndrome. J Transl Med. 2021;19(1):148. PubMed 33849562
- Al Zunaidy NA, Al-Khalifa AS, Alhussain MH, et al. The effect of Ramadan intermittent fasting on anthropometric, hormonal, metabolic, inflammatory, and oxidative stress markers in pre- and post-menopausal women: a prospective cohort of Saudi women. Front Nutr. 2024;11:1437169. PubMed 39698238
- Yavangi M, Amirzargar MA, Amirzargar N, Dadashpour M. Does Ramadan fasting has any effects on menstrual cycles? Iran J Reprod Med. 2013;11(2):145-150. PubMed 24639740
- Jirapak A, Adams E, Black GM, Devlin BL. Impact of time-restricted eating on reproductive hormones and androgen markers in adult females: a systematic review. Nutr Health. 2026;32(6):1873-1884. PubMed 42429418
- Kumar S, Kaur G. Intermittent fasting dietary restriction regimen negatively influences reproduction in young rats: a study of hypothalamo-hypophysial-gonadal axis. PLoS One. 2013;8(1):e52416. PubMed 23382817
- NHS. Missed or late periods. nhs.uk
- Alfaro-Magallanes VM, Medrano M, Echarte J, et al. Effects of time-restricted eating and resistance training on skeletal muscle tissue quantity, quality and function in postmenopausal women with overweight or obesity: a study protocol. Nutr Metab Cardiovasc Dis. 2025;35(5):103844. PubMed 39939249
- ClinicalTrials.gov. Time Restricted Eating for Weight Management (NCT04692532), University of Illinois Chicago: eligibility and baseline characteristics. clinicaltrials.gov
Newsletter · Weekly
The weekly peptide briefing.
New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.